BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Drop in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 300 shares, a drop of 76.9% from the February 28th total of 1,300 shares. Based on an average trading volume of 2,200 shares, the short-interest ratio is presently 0.1 days.

BioSyent Price Performance

BIOYF remained flat at $7.88 during trading hours on Friday. The company had a trading volume of 101 shares, compared to its average volume of 3,119. BioSyent has a one year low of $5.93 and a one year high of $8.90. The company’s 50-day moving average price is $7.72 and its 200-day moving average price is $7.89.

BioSyent Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, March 3rd were given a dividend of $0.0347 per share. The ex-dividend date was Friday, February 28th. This represents a yield of 1.77%. This is a boost from BioSyent’s previous dividend of $0.03.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.